Oxford Science Enterprises portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million
OXFORD, England, Aug. 4, 2022 /PRNewswire/ — Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, is pleased to announce its life sciences portfolio…
Comments Off on Oxford Science Enterprises portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million